Reporte zur Charge 006M20A029L20A

Symptomtext

Peripheral neuropathy on both of her legs; Soreness on the injection site; The site was more itchy; inappropriate schedule of vaccine administered; Numbness; This spontaneous case was reported by a consumer and describes the occurrence of NEUROPATHY PERIPHERAL (Peripheral neuropathy on both of her legs) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A006M20A and 006M20A029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event (no historical condition reported.). On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In February 2021, the patient experienced HYPOAESTHESIA (Numbness). On 23-Feb-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (inappropriate schedule of vaccine administered). On 24-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (The site was more itchy). On an unknown date, the patient experienced NEUROPATHY PERIPHERAL (Peripheral neuropathy on both of her legs) (seriousness criterion medically significant) and VACCINATION SITE PAIN (Soreness on the injection site). In February 2021, HYPOAESTHESIA (Numbness) had resolved. On 23-Feb-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (inappropriate schedule of vaccine administered) had resolved. At the time of the report, NEUROPATHY PERIPHERAL (Peripheral neuropathy on both of her legs) had resolved and VACCINATION SITE PRURITUS (The site was more itchy) and VACCINATION SITE PAIN (Soreness on the injection site) outcome was unknown. Concomitant product use was not provided by the reporter. No treatment information was provided. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Most recent FOLLOW-UP information incorporated above includes: On 31-Mar-2021: Event: Numbness start date and recovered date updated.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.